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Abstract
Introduction. The distribution of the immunoreactive cell bodies and fibers containing neurotensin in the alpaca 
diencephalon was determined by an immunohistochemical technique.
Material and methods. The study was carried out in four male alpacas that lived at sea level. Brains of deeply 
anesthetized animals were fixed by perfusion with 4% paraformaldehyde. Cryostat sections were stained by 
a standard immunohistochemical method.
Results. Cell bodies containing neurotensin were observed in the zona incerta and hypothalamus. A low/moder-
ate density of these cell bodies was observed in the lateral hypothalamic area, anterior and dorsal hypothalamic 
areas, suprachiasmatic nucleus, periventricular region of the hypothalamus and in the ventromedial hypothalamic 
nucleus. In both thalamus and hypothalamus, immunoreactive fibers showed a widespread distribution. In the 
thalamus, a high density of these fibers was mainly found in the midline nuclei, whereas in the hypothalamus 
a high density was in general observed in the whole structure. 
Conclusions. In comparison with other mammals, the thalamus of the alpaca showed the most widespread dis-
tribution of neurotensin-immunoreactive fibers. The widespread distribution of neurotensin through the alpaca 
diencephalon suggests that the peptide can be involved in many physiological actions. (Folia Histochemica et 
Cytobiologica 2018, Vol. 56, No. 1, 49–58)
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Introduction
Many immunohistochemical and radioimmunoassay 
studies have been carried out on the distribution of 
the tridecapeptide neurotensin in the mammalian 
central nervous system [1–11]. In the species studied 
(e.g., rat, guinea pig, cat, minipig, monkey, man), 
these works have reported a widespread distribution 
of neurotensin in the central nervous system and this 
suggests that the peptide might be involved in many 
physiological actions. In fact, neurotensin, acting 
as a neurotransmitter and/or neuromodulator, has 
been involved in several physiological actions af-
fecting hemodynamic, neuroendocrine, food intake, 
nociceptive, thermoregulatory, locomotor, respira-
tory, sleep-waking, gustatory, memory, auditory and 
glucoregulatory systems [1, 9, 12–16]. Moreover, it 
is known that neurotensin promotes the dendritic 
spine maturation and dendrite elongation [17] and 
modulates high-voltage-activated calcium currents 
[18]. The neurotensin/neurotensin receptor system 
is also involved in cancer (e.g., neuroendocrine tum-
ors, leukemia, pancreatic adenocarcinoma) [19–21]. 
Despite the data on the distribution of neurotensin in 
the mammalian central nervous system (CNS) [1–11], 
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the presence of neurotensin in camelids has not been 
reported, with the exception of alpaca (Lama pacos), 
in which its presence in the brainstem was demon-
strated by immunohistochemistry [12]. The alpaca is 
a camelid very important for some countries in South 
America (e.g., Peru). Due to the economic importance 
of the wool production, several studies have been 
published on the reproductive mechanisms of these 
animals [22–26]. Moreover, since 2007, the chemical 
neuroanatomy of neuropeptides in the alpaca CNS 
has increased considerably. Using immunohisto-
chemical (IHC) techniques, the distribution of calci-
tonin gene-related peptide, somatostatin-28 (1-12), 
leucine-enkephalin, adrenocorticotropic hormone, 
beta-endorphin (1-27), alpha-melanocyte-stimulating 
hormone and alpha-neo-endorphin has been reported 
in the alpaca’s CNS [27–32]. However, to date no 
data are currently available in the literature detailing 
the location of either fibers or cell bodies containing 
neurotensin in alpaca’s diencephalon, a CNS region 
involved in many important functional mechanisms. 
Therefore, the aims of this study were to examine the 
distribution of immunoreactive structures containing 
neurotensin in the diencephalon of alpaca using im-
munohistochemistry. 
Material and methods
Animals. Four male adult alpacas (Lama pacos) (Huacaya 
race) (5–8 years; 70–80 kg) were obtained from the Peru-
vian University Cayetano Heredia (Faculty of Veterinary 
Medicine and Animal Sciences, Lima, Peru). The experi-
mental design, protocols, and procedures of this work were 
performed under the principles of laboratory animal care 
and under the guidelines of the ethical and legal recommen-
dations of Peruvian and Spanish legislation. This work was 
also approved by the research commission of the Peruvian 
University Cayetano Heredia (Lima, Peru). The animals 
were kept all their life at the altitude of 0 m under standard 
conditions of light (lights on at 06:00 and off at 20.00 h) and 
temperature (26° C), and had free access to food and water. 
Tissue preparation. As previously reported [27–32], animals 
were deeply anesthetized with ketamine (10 mg/kg) and 
xylazine (4 mg/kg) (both intravenously), heparinized, and 
perfused via the carotid artery with 3 l of cold 0.9% NaCl. 
This pre-rinse was immediately followed by infusion of the 
fixative: 5 l of cold 4% paraformaldehyde in 0.15 M phos-
phate-buffered saline (PBS) (pH 7.2). The diencephalons 
were dissected out and post-fixed overnight in the latter 
solution and cryoprotected by immersion in increasing 
concentrations of sucrose solution (10–30%) until they sank. 
Using a cryostat, 50-mm frontal sections were cut, collected 
in PBS and kept at 4° C. 
Immunohistochemistry. The IHC procedure has been car-
ried out as described previously [12]. In order to avoid possi-
ble interference by endogenous peroxidase, free-floating sec-
tions were treated with a mixture of NH3, NaOH and H2O2 
(Panreac, Barcelona, Spain) for 20 min. Then, sections were 
washed in PBS (3 × 10 min) and pre-incubated for 30 min 
in PBS containing 1% normal horse serum (Sigma-Aldrich, 
Madrid, Spain) and 0.3% Triton X-100 (Panreac, Barcelona, 
Spain) in order to enhance antibody penetration. Then, 
sections were incubated overnight at 4° C in the same phos-
phate buffer containing the anti-neurotensin antibody (gift 
of Professor Gérard Tramu), diluted 1:3,000. Sections were 
then rinsed extensively in PBS for 30 min and incubated for 
1 h at room temperature with biotinylated anti-rabbit IgG 
(Vector Laboratories, Burlingame, CA, USA) diluted 1:200 
in the same buffer. Thereafter, sections were incubated 
with Vectastain ABC reagent (Vector Laboratories) for 
1 h at room temperature. After washing the sections in PBS 
(30 min) and Tris-HCl buffer (Panreac, Barcelona, Spain) 
(pH 7.6) (10 min), the tissue-bound peroxidase was 
developed with H2O2, using 3, 3’-diaminobenzidine (Sig-
ma-Aldrich) as chromogen. Finally, sections were rinsed 
with PBS and coverslipped with PBS/glycerol (1/1).
Specificity of the antisera. The polyclonal anti-neurotensin 
antibody (obtained in the laboratory of Professor Gérard 
Tramu, University of Bordeaux I, France) was raised in 
rabbits as previously reported [12]. Moreover, the immu-
nological properties of the anti-neurotensin antiserum have 
been published previously [12, 33].
In this work, the specificity of the immunostaining was 
checked by: 1) preabsorption of the primary antiserum 
with synthetic neurotensin (Sigma-Aldrich) (100 µg/mL of 
diluted antiserum) (Fig. 3b); 2) omitting the neurotensin 
antiserum in the first incubation bath (Fig. 3e); and 3) 
preabsorption of anti-neurotensin with an excess (10-7 M) 
of synthetic substance P, angiotensin II, beta-endorphin, 
somatostatin-28 (1-12), vasoactive intestinal peptide, and 
neuropeptide Y (Sigma-Aldrich). In all cases, the results 
confirmed the specificity of the antisera used in this study.
Mapping. Mapping was carried out following the frontal 
planes of the alpaca diencephalon that have been pub-
lished in previous articles addressing the distribution of 
neuropeptides in alpaca’s diencephalon [27–32, 34]. For 
each frontal plane of the alpaca diencephalon, 5–8 sections 
were studied. For nomenclature of the diencephalic nuclei, 
we used that published in the previous papers [27, 28, 32, 
34]. Moreover, the brain atlas of Lama glama (available 
from the Mammalian Brain Collections of the University of 
Wisconsin, Madison, U.S.A.) was used. A series of sections 
contiguous to those reactive for the neuropeptide studied 
were routinely stained for Nissl substance with cresyl violet 
in order to identify and delineate the different nuclei of 
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the diencephalon in which immunoreactive structures were 
found [27–32, 34]. 
As previously reported [27, 28], in order to determine 
the density of the immunoreactive fibers in alpaca’s dien-
cephalon these were graded into four categories under 
microscopic observation: high, moderate, low and single 
(a few immunoreactive fibers). This was accomplished 
following the protocol described by Coveñas et al. [35], and 
involved viewing the sections under bright-light illumination 
at constant magnification with reference to photographs in 
which the density (high, moderate and low) of the immuno-
reactive fibers had been established previously. Additionally, 
the length of the immunoreactive fibers was considered as 
short (< 90 µm), medium (90–120 µm) or long (> 120 µm) 
as previously described [27]. Measurement of the size of the 
immunoreactive cell bodies containing neurotensin studied 
here was carried out as previously described [35]: cell bodies 
with a diameter of < 15 µm were considered small; those 
with a diameter between 15–25 µm were medium-sized, 
and those with a diameter > 25 µm were large. The sizes 
of the immunopositive cell bodies were measured using 
a micrometer grid with the nuclei in the focal plane. The 
number of immunostained cell bodies appearing in each 
section was counted; a high density of cell bodies was consid-
ered when we found more than 20 cell bodies/region/section; 
a moderate density when we found 10–20 cell bodies/region/ 
/section, and a low density when we found fewer than 10 cell 
bodies/region/section [27, 28].
Photomicrographs were obtained with an Olympus 
DP50 digital camera (Olympus, Tokyo, Japan) attached to 
a Kyowa Unilux 12 microscope (Kyowa, Tokyo, Japan). To 
improve the visualization of the results, only the brightness 
and contrast of the images were adjusted, without any fur-
ther manipulation of the photographs. Adobe Photoshop 
CS6Software was used to view the images and adjust their 
brightness and contrast.
Results
General considerations
The distribution of the immunoreactive fibers and 
cell bodies containing neurotensin in the alpaca dien-
cephalon is shown in Table 1 and in Figures 1–4. Cell 
bodies containing neurotensin were found in the zona 
incerta and in the hypothalamus. In the latter struc-
ture, seven clusters of immunoreactive cell bodies 
were visualized. In all cases, a low/moderate density 
of these cell bodies was observed. In general, these 
cell bodies were round or fusiform and medium-large 
in size, showing 2–3 dendrites. The thalamus was de-
void of cell bodies containing neurotensin. In both, 
thalamus and hypothalamus immunoreactive fibers 
showed a widespread distribution. In the thalamus, 
a high density of these fibers was mainly found in the 
midline nuclei, whereas in the hypothalamus a high 
density was in general observed by the whole struc-
ture. In general, immunoreactive fibers were thin, 
short or medium in length, non-branched and with 
varicosities. In general, in the four diencephalons used 
in this study, the distribution of the immunoreactive 
structures (fibers and cell bodies) and the density of 
such structures were quite similar. 
Immunoreactive cell bodies
A low density of cell bodies containing neurotensin 
has been observed in the zona incerta (Fig. 1d, e). 
In the hypothalamus, a moderate density was found 
above the fornix (Fig. 1b, c) and in the caudal part of 
the lateral hypothalamic area (Fig. 1d, e), whereas 
a low density was observed in the anterior (Fig. 1a) 
and dorsal hypothalamic areas (Fig. 1c, 2b), rostral 
part of the lateral hypothalamic area (Fig. 1a–c, 2c, d), 
suprachiasmatic nucleus (Fig. 1a, 2e, f), periventricu-
lar region of the hypothalamus (Fig. 1b, c and 3b) and 
in the ventromedial hypothalamic nucleus (Fig. 1b, c).
Immunoreactive fibers
In the thalamus, a high density of immunoreactive 
fibers was observed in the central medial (Fig. 1b–e), 
reuniens (Fig. 1a–d, 3c), rhomboid (Fig. 1b, c, 3d), 
subparafascicular (Fig. 1e) and dorsal part of the 
reticular thalamic nuclei (Fig. 1a–d) and a moderate 
density in the anterodorsal thalamic nucleus (Fig. 1a, 
b) and in the paraventricular thalamic nucleus (Fig. 
1a–e, 3e). Single immunoreactive fibers were visu-
alized in the medial habenular nucleus (Fig. 1d, e), 
paracentral thalamic nucleus (Fig. 1c, d) and in the 
medial and lateral parts of the ventroposterior tha-
lamic nucleus (Fig. 1c–e) and a low density in the 
anteromedial (Fig. 1a, b), anteroventral (Fig. 1a, b), 
centrolateral (Fig. 1c, d), laterodorsal (Fig. 1c–e), 
lateroposterior (Fig. 1d, e), ventroanterior (Fig. 1a), 
ventrolateral (Fig. 1b), ventromedial (Fig. 1b–d), 
reticular (Fig. 1a–e) and mediodorsal (Fig. 1b–e, 4d) 
thalamic nuclei and in the lateral habenular nucleus 
(Fig. 1d, e). A low density of immunoreactive fibers 
was also observed in the zona incerta (Fig. 1d, e, 4f).
In the hypothalamus, a high density of immunore-
active fibers containing neurotensin was found in the 
anterior, dorsal and lateral hypothalamic areas (Fig. 
1a–e), lateral mammillary nucleus (Fig. 1e), periven-
tricular region (Fig. 1a–e), around the fornix (Fig. 
1a–d, 4b, c), posterior hypothalamic nucleus (Fig. 1d, 
e, 4e), median eminence (Fig. 1c), paraventricular 
hypothalamic nucleus (Fig. 1a, b, 3f), suprachiasmatic 
nucleus (Fig. 1a) and in the ventromedial hypothalam-
ic nucleus (Fig. 1b, c). A moderate density was found 
in the arcuate nucleus (Fig. 1c, d) and single fibers 
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in the medial mammillary nucleus (Fig. 1e) and the 
supraoptic hypothalamic nucleus (Fig. 1a, b).
Discussion
This is the first report describing the distribution of 
immunoreactive structures containing neurotensin 
in the alpaca diencephalon. The neuroanatomical 
findings reported here add to our current knowledge 
about the neurotensinergic system in the camelid 
central nervous system, since the mapping of neu-
rotensin-immunoreactive fibers and cell bodies in the 
alpaca brainstem has been carried out previously [12]. 
The origin of the immunoreactive fibers in the alpaca 
diencephalon is unknown as well as we have no data 
indicating whether the neurotensin-immunoreactive 
cell bodies observed in the alpaca diencephalon are 
local and/or projecting neurons. However, our data 
suggest that many neurons could be projecting neu-
rons, since a widespread distribution of immunoreac-
tive fibers containing neurotensin has been observed. 
It is important to note that this study was carried out 
in animals not treated with colchicine and it is known 
that sometimes the visualization of a widespread 
distribution of peptidergic cell bodies only occurred 
in colchicine-treated animals [30]. Because the ad-
ministration of colchicine in alpacas must be ruled 
out for ethical reasons, other techniques (e.g., in situ 
hybridization) must be used to elucidate the complete 
distribution of neurons containing neurotensin in the 
alpaca diencephalon.
The widespread distribution of the neurotensiner-
gic system observed in the alpaca diencephalon sug-
gests that the neuropeptide might be involved in many 
physiological mechanisms, as it has been reported in 
other mammals. Thus, neurotensin would be involved 
Table 1. Density of fibers and cell bodies containing neurotensin in the alpaca diencephalon
Hypothalamic nuclei
Nuclei Cell Bodies Fibers Nuclei Cell bodies Fibers
Anterior hypothalamic area (AHy) + +++ Median eminence (ME) – +++
Arcuate nucleus (Arc) – ++ Paraventricular hypothalamic nucleus (PVH) – +++
Dorsal hypothalamic area (DA) + +++ Perifornical region. Above the Fornix (f) ++ +++
Fornix (f) – – Periventricular area of the hypothalamus + +++
Lateral hypothalamic area (LH) +/++ +++ Posterior hypothalamic nucleus (PH) – +++
Lateral mammillary nucleus (LM) – +++ Suprachiasmatic nucleus (sch) + +++
Mammillothalamic tract (mt) – – Supraoptic hypothalamic nucleus (SO) – s
Medial mammillary nucleus (MM) – s Ventromedial hypothalamic nucleus (VMH) + +++
Thalamic nuclei
Nuclei Cell bodies Fibers Nuclei Cell bodies Fibers
Anterodorsal thalamic nucleus (AD) – ++ Reticular thalamic nucleus (Rt) – +/+++
Anteromedial thalamic nucleus (AM) – + Reuniens thalamic nucleus (Re) – +++
Anteroventral thalamic nucleus (AV) – + Rhomboid thalamic nucleus (Rh) – +++
Central medial thalamic nucleus (CM) – +++ Stria medullaris (sm) – –
Centrolateral thalamic nucleus (CL) – + Subparafascicular thalamic nucleus (SPF) – +++
Lateral geniculate nucleus (LG) – – Subthalamic nucleus (STh) – s
Lateral habenular nucleus (LHb) – + Ventroanterior thalamic nucleus (VA) – +
Laterodorsal thalamic nucleus (LD) – + Ventrolateral thalamic nucleus (VL) – +
Lateroposterior thalamic nucleus (LP) – + Ventromedial thalamic nucleus (VM) – +
Medial habenular nucleus (MHb) – s Ventroposterior thalamic nucleus, lateral part (VPL) – s
Mediodorsal thalamic nucleus (MD) – + Ventroposterior thalamic nucleus, medial part (VPM) – s
Paracentral thalamic nucleus (PC) – s Zona incerta (ZI) + +
Paraventricular thalamic nucleus (PVA) – ++
Cell bodies (+ — low density; ++ — moderate density); Fibers (s — single fibers; + — low density; ++ — moderate density; +++ — high den-
sity). – denotes lack of immunoreactivity.
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in feeding, sexual activity, vigilance behavior, home-
ostasis, thermogenesis and neuroendocrine mecha-
nisms [3, 5, 8, 13]. Future studies should be focused 
on such possible functions and on the distribution of 
neurotensin receptors in the alpaca diencephalon.
Neuropeptides in the alpaca diencephalon
In order to compare adequately the distribution of 
neuropeptides in the alpaca diencephalon, here male 
alpacas were only used, since in previous works in 
which the distribution of neuropeptides was carried 
out; male animals were exclusively used [27–32]. 
Moreover, all animals, used here and in the previ-
ous studies, were always maintained at 0 m on the 
sea level (from birth to death) and were not treated 
with colchicine. The distribution of immunoreac-
tive structures containing calcitonin gene-related 
peptide (CGRP), adrenocorticotropic hormone 
(ACTH), leucine-enkephalin, beta-endorphin (1-27), 
alpha-melanocyte-stimulating hormone (aMSH) or 
alpha-neo-endorphin and somatostatin-28 (1-12) has 
been previously reported in the alpaca diencephalon 
[27, 28, 32]. 
In all the thalamic and hypothalamic nuclei in 
which we have observed neurotensin-immunoreactive 
fibers, the presence of fibers containing beta-en-
dorphin (1-27), aMSH, alpha-neo-endorphin or 
somatostatin-28 (1-12) has been also reported [27, 
28, 32]. Moreover, fibers containing CGRP, ACTH, 
or leucine-enkephalin [28, 32] were observed in all 
the hypothalamic nuclei in which we have visualized 
neurotensin-immunoreactive fibers. Thus, there is 
a close anatomical relationship in the alpaca dien-
cephalon between the above-mentioned neuropep-
tides. Moreover, the data suggest a possible functional 
interaction between these neuropeptides and a pos-
sible coexistence of them. 
Our study shows for the first time in the alpaca 
diencephalon the presence of peptidergic cell bodies 
in the suprachiasmatic nucleus and zona incerta. 
Figure 1. Distribution of neurotensin-immunoreactive fibers and cell bodies in frontal planes of the alpaca diencephalon 
from rostral (a) to caudal levels (e). Cell bodies are represented by closed squares (low density) and triangles (moderate 
density). Immunoreactive fibers are represented by slightly dark (low density or single fibers), moderately dark (moderate 
density) and strongly dark (high density). Abbreviations: III — third ventricle; AD — anterodorsal thalamic nucleus; AHy 
— anterior hypothalamic area; AM — anteromedial thalamic nucleus; Arc — arcuate nucleus; AV — anteroventral thalamic 
nucleus; CL — centrolateral thalamic nucleus; CM — central medial thalamic nucleus; cp — cerebral peduncle; DA — dorsal 
hypothalamic area; f — fornix; ic — capsula interna; LD — laterodorsal thalamic nucleus; LG — lateral geniculate nucleus; 
LH — lateral hypothalamic area; LHb — lateral habenular nucleus; LM — lateral mammillary nucleus; LP — lateroposte-
rior thalamic nucleus; MD — mediodorsal thalamic nucleus; ME — median eminence; MHb — medial habenular nucleus; 
MM — medial mammillary nucleus; mt — mammillothalamic tract; opt — optic tract; ox — optic chiasm; PC — paracentral 
thalamic nucleus; PH — posterior hypothalamic nucleus; PVA — paraventricular thalamic nucleus; PVH — paraventricular 
hypothalamic nucleus; Re — reuniens thalamic nucleus; Rh — rhomboid thalamic nucleus; Rt — reticular thalamic nucleus; 
sch — suprachiasmatic nucleus; sm — stria medullaris; SO — supraoptic hypothalamic nucleus; SPF — subparafascicular 
thalamic nucleus; STh — subthalamic nucleus; VA — ventroanterior thalamic nucleus; VL — ventrolateral thalamic nucle-
us; VM — ventromedial thalamic nucleus; VMH — ventromedial hypothalamic nucleus; VPL — ventroposterior thalamic 
nucleus, lateral part; VPM — ventroposterior thalamic nucleus, medial part; ZI — zona incerta.
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In the lateral hypothalamic area and in the ventrome-
dial hypothalamic nucleus, cell bodies containing neu-
rotensin, aMSH, alpha-neo-endorphin, somatosta-
tin-28 (1-12) or CGRP have been reported [27, 28, 32]. 
According to the morphological characteristics (e.g., 
size, shape) of the peptidergic neurons located in both 
hypothalamic nuclei [27, 28, 32], it seems that a pos-
sible coexistence of these neuropeptides could occur. 
The administration of CGRP into the ventromedial 
hypothalamic nucleus increases the temperature of 
the interscapular brown adipose tissue, heart rate, 
oxygen consumption and colonic temperature [36]. 
In the anterior and dorsal hypothalamic areas, cell 
bodies containing neurotensin or CGRP have been 
also located [28]. In future studies, the coexistence 
of both neuropeptides should be addressed in the 
anterior and dorsal hypothalamic areas.
Neurotensin in the mammalian diencephalon
The distribution of fibers and cell bodies containing 
neurotensin has been carried out studied in rat, cat and 
human diencephalons [3, 5, 8, 11]. It should be noted 
that, here, we have used the same anti-neurotensin 
antiserum and applied the same immunohistochemical 
method that in the study carried out in the feline [3]. 
In general, in the hypothalamus, the neurotensinergic 
Figure 2. Neurotensin-immunoreactive cell bodies (arrowheads) in the alpaca hypothalamus. (A) Frontal section of the 
diencephalon at the level of the optic chiasm (ox). For nomenclature of the nuclei and tracts, see list of abbreviations in 
Figure 1. The photographs shown in C–F were respectively taken from the regions delimited by the rectangles in A (indicated 
as Fig. c–d and Fig. e–f). Cell bodies containing the peptide located in (B) the dorsal hypothalamic area (DA) (see Fig. 1c), 
(C, D) the lateral hypothalamic area (LH) and (E, F) in the suprachiasmatic nucleus (Sch). Arrows: immunoreactive fibers.
A B
C D
E F
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innervation in rat, cat, alpaca and humans is quite 
similar since in these four species neurotensin-immu-
noreactive fibers have been found through the whole 
hypothalamus [3, 5, 8, 11]. Moreover, in the four 
species neurotensin-immunoreactive fibers have been 
observed in the thalamus along the midline [3, 5, 8, 11]. 
However, in rat, cat and humans, neurotensin-immuno-
reactive fibers were totally absent in the lateral region 
of the thalamus (e.g., reticular thalamic nucleus) [3, 5, 
8, 11], but in the alpaca we observed immunoreactive 
fibers containing neurotensin in the lateral thalamic nu-
clei. This means that, among the mammalian thalamus, 
the alpaca shows the most widespread distribution of 
neurotensin-immunoreactive fibers. It seems that this 
discrepancy is due to species differences and suggests 
that neurotensin could be involved in special and 
unique regulatory mechanisms in the lateral thalamic 
nuclei of the alpaca. 
Figure 3. Neurotensin-immunoreactive cell bodies (arrowhead) and fibers (arrows) in the alpaca diencephalon. (A) Frontal 
section of the diencephalon at the level of the optic tract (opt). For nomenclature of the nuclei and tracts, see list of abbre-
viations in Figure 1. The photographs shown in B–F were respectively taken from the regions delimited by the rectangles in 
a (indicated as Fig. B–F). (B) Immunoreactive cell body located in the periventricular region of the hypothalamus. Inset: 
absence of immunoreactivity in the periventricular region of the hypothalamus when the preabsorption of the anti-neuroten-
sin antibody was carried out with neurotensin. Immunoreactive fibers in the reuniens thalamic nucleus (Re) (C), rhomboid 
thalamic nucleus (D), paraventricular thalamic nucleus (PVA) (E) (inset in (e): absence of immunoreactivity in the paraven-
tricular thalamic nucleus (PVA) when the anti-neurotensin antibody was omitted) and in the paraventricular hypothalamic 
nucleus (F) (inset at bottom right: a higher magnification of the upper rectangle).
A B
C D
E F
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Regarding the distribution of thalamic neuroten-
sin-immunoreactive cell bodies, they are more widely 
distributed in cat than in rat, alpaca and human [3, 
5, 8, 11]. In the two latter species, neurotensin-im-
munoreactive cell bodies were not observed [8]. This 
discrepancy could be due to technical considerations, 
since in both rats and cats intraventricular injections 
of colchicine were carried out [5, 11]. Regarding the 
hypothalamus, rats, cats and humans [3, 5, 8, 11] 
showed a more widespread distribution of neuroten-
sin-immunoreactive cell bodies than that observed in 
the alpaca. In these four species, cell bodies containing 
neurotensin were found in the lateral hypothalamic 
area, ventromedial hypothalamic nucleus and in the 
suprachiasmatic nucleus. In the arcuate nucleus, 
neurotensin-immunoreactive cell bodies have been 
visualized in rat, cat and humans, but not in alpacas. 
The discrepancy in the distribution of cell bodies con-
taining neurotensin in the mammalian hypothalamus 
could be due to technical considerations (e.g., primary 
antisera used, administration of colchicine) and/or 
species differences.
In summary, this study increases our knowledge 
of the chemical neuroanatomy of neurotensin in 
Figure 4. Neurotensin-immunoreactive fibers (arrows) in the alpaca diencephalon. (A) Frontal section of the diencephalon 
at the level of the median eminence (ME). For nomenclature of the nuclei and tracts, see list of abbreviations in Figure 1. 
The photographs shown in B–D were respectively taken from the regions delimited by the rectangles in a (indicated as 
Fig. b–c and Fig. d). (B) Immunoreactive fibers around the fornix (f). (C) A higher magnification of the region delimited 
by the rectangle in B. Fibers containing the peptide located in the (D) mediodorsal thalamic nucleus (MD), (E) posterior 
hypothalamic nucleus (PH) (see Fig. 1d, e) and (F) in the zona incerta (ZI) (see Fig. 1d, e).
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camelids, since a previous study described the dis-
tribution of immunoreactive structures (cell bodies 
and fibers) containing neurotensin in the alpaca 
brainstem [12]. The mapping of neurotensin in the 
alpaca diencephalon may help to better understand 
the involvement of this neuropeptide in its multiple 
physiological actions.
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